The present study will compare the effectiveness of adhesive nasoalveolar molding (GS-NAM) and conventional nasoalveolar molding on the alveolar ridge, nasal, and labial growth in children with unilateral cleft lip and palate.
objectives: -
1. Evaluation of the anatomical position of the greater and lesser segments of the maxilla related to a stable midline anatomical point. 2. Evaluation of the nasal symmetry.
Age: 1- 8 weeks.
Gender: male and female.
Patients with a unilateral cleft alveolus and lip.
No developmental syndromes or atypical cleft pathology in medical history.
Patients with a bilateral cleft alveolus and lip
Syndromic patient
Uncooperative caregiver
Parallel
Nasoalveolar molding in unilateral cleft lip and palate
Devicecompare the effectiveness of adhesive nasoalveolar molding (GS-NAM) and conventional nasoalveolar molding on the alveolar ridge, nasal, and labial growth in children with unilateral cleft lip and palate
Posterior ends of alveolar crest
width between the most posterior ends of the alveolar crest in the greater segment and lesser segment
Middle ends of alveolar crest
width between the middle parts of the cleft palate (The intersection points between the palatally extended buccal frenum sulcus line and the palatal gingival groove in the greater and lesser segment
Anterior ends of alveolar crest
The widths of the cleft gap (The anterior endpoint of the alveolar crest in the greater and lesser segment)
Mid line of maxilla
Inc-Sagittal: - Perpendicular distance from Inc point (The intersection points between the labial frenum-incisive papilla point line and the alveolar crest of the premaxilla in the greater segment) to sagittal line (The perpendicular line to the PG-PL line)
Alar base width
Total width correction of alar base width.
Columella length.
Columella length correction
Columella angle deviation.
Columella angle deviation correction
Nostril height and width on the cleft side.
Nostril height and width on the cleft side correction
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
